Close Menu

Beckman Coulter

This story was originally published May 14.
Beckman Coulter Genomics has received CLIA certification for its sequencing services facility as it looks to develop assays for both Sanger and next-gen sequencing platforms.

NEW YORK (GenomeWeb News) – Beckman Coulter said after the close of the market on Tuesday that it has received CLIA certification and Massachusetts State Licensure, allowing its genomics operations to begin accepting clinical samples for genetic sequencing.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Danaher today reported its first-quarter revenues increased 31 percent year over year driven by acquisitions, including the Beckman Coulter purchase.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Beckman Coulter Life Sciences announced late Thursday it has acquired flow cytometry firm Blue Ocean Biomedical for an undisclosed amount.

Beckman Coulter has launched SPRIworks HT, a high-throughput fragment library prep kit for Illumina sequencing platforms.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – The US Food and Drug Administration has issued a warning letter to Beckman Coulter citing issues it identified at the company's Miami facility.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Danaher today reported a 46 percent increase in sales year over year for the third quarter, beating analysts' estimates on the top and bottom line.

Indiana University's Center for Genomics and Bioinformatics has inked a deal with Beckman Coulter to develop genomics applications that can identify toxins that are harmful to the environment and human health.

Pages

CBS This Morning highlights recent Medicare fraud involving offers of genetic testing.

Researchers find that many cancer drugs in development don't work quite how their developers thought they did, as Discover's D-brief blog reports.

Mariya Gabriel, a Bulgarian politician, is to be the next European Union research commissioner, according to Science.

In Science this week: a survey indicates that US adults are more likely to support the agricultural use of gene drives if they target non-native species and if they are limited, and more.